Fresenius SE & Co. KGaA Logo

Fresenius SE & Co. KGaA

Provides critical biopharma, medtech, and hospital care for critically & chronically ill patients.

FRE | F

Overview

Corporate Details

ISIN(s):
CH1298665980 (+4 more)
LEI:
XDFJ0CYCOO1FXRFTQS51
Country:
Germany
Address:
Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Fresenius SE & Co. KGaA is a global healthcare company providing system-critical products and services for the care of critically and chronically ill patients. The Group comprises two primary operating companies, Fresenius Kabi and Fresenius Helios, and holds a strategic investment in Fresenius Medical Care. Fresenius Kabi specializes in a wide range of biopharmaceuticals, clinical nutrition, medical technologies, and intravenous generic drugs. Fresenius Helios is a leading private hospital and outpatient care operator in Germany and Spain. Through its #FutureFresenius strategic program, the company is focused on strengthening its core platforms—(Bio)Pharma, MedTech, and Care Provision—to drive innovation and long-term growth.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-06 00:00
Interim Report
Half-yearly financial report 2025
English 719.4 KB
2025-07-04 08:03
Declaration of Voting Results & Voting Rights Announcements
English 77.9 KB
2025-06-20 11:34
Declaration of Voting Results & Voting Rights Announcements
German 16.2 KB
2025-05-07 00:00
Quarterly Report
Q1 statement / Q1 financial report 2025
English 1.4 MB
2025-04-24 00:00
Annual Report
Annual financial report 2024
English 11.6 MB
2025-04-17 00:00
Governance Information
Corporate Governance Declaration and Report 2024 of Fresenius SE & Co. KGaA
English 618.6 KB
2025-04-09 15:05
Pre-Annual General Meeting Information
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting …
English 3.6 KB
2025-04-02 14:40
Director's Dealing
Fresenius SE & Co. KGaA: Robert Moller, buy
English 6.5 KB
2025-04-01 16:16
Declaration of Voting Results & Voting Rights Announcements
English 16.1 KB
2025-04-01 14:22
Director's Dealing
Fresenius SE & Co. KGaA: Sara Hennicken, buy
English 6.5 KB
2025-03-24 16:09
Declaration of Voting Results & Voting Rights Announcements
English 72.3 KB
2025-03-21 18:10
Major Shareholding Notification
English 72.3 KB
2025-03-06 18:55
Declaration of Voting Results & Voting Rights Announcements
English 72.4 KB
2025-03-04 18:03
M&A Activity
Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake …
English 18.0 KB
2025-03-03 18:03
Major Shareholding Notification
Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake …
English 18.0 KB

Automate Your Workflow. Get a real-time feed of all Fresenius SE & Co. KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Fresenius SE & Co. KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-08-04 Moser, Dr. Michael Board Buy None 300,565.98 EUR
2023-04-03 Sen, Michael Board Buy None 586,989.25 EUR
2023-04-03 Hennicken, Sara Board Buy None 49,839.92 EUR
2022-11-18 De Meo, Dr. Francesco Board Buy None 50,415.29 EUR
2022-08-29 De Meo, Dr. Francesco Board Sell None 50,831.20 EUR
2022-08-05 Sturm, Stephan Board Buy None 119,831.44 EUR
2022-08-05 Sturm, Stephan Board Buy None 119,676.59 EUR
2022-08-05 Schmitt, Martin Board Buy None 5,150.00 EUR
2022-06-10 Sturm, Stephan Board Other None 54,089.64 EUR
2022-06-10 Kirsch, Wolfgang Supervisory board Other None 6,901.09 EUR

Peer Companies

Company Country Ticker View
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
T&R Biofab Co., Ltd Logo
Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.
South Korea 246710
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea 337840
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
Sweden VITR
Vitruvia Medical AG Logo
Circular economy provider for robotic surgery instruments for European clinics and hospitals.
Germany 991
Wonbiogen Co.,Ltd. Logo
Develops and manufactures advanced wound care solutions and medical materials.
South Korea 307280
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO

Talk to a Data Expert

Have a question? We'll get back to you promptly.